The Directory of Open Access Journals
DOAJ Logotype
Open
Global
Trusted
Main actions
Support
Institutions and libraries
Publishers
Institutional and library supporters
Apply
Application form
Guide to applying
The DOAJ Seal
Transparency & best practice
Publisher information
Licensing & copyright
Search
Menu
Secondary actions
Search
Journals
Articles
Documentation
API
OAI-PMH
Widgets
Public data dump
OpenURL
XML
Metadata help
Preservation
About
About DOAJ
DOAJ at 20
DOAJ team
Ambassadors
Advisory Board & Council
Editorial Policy Advisory Group
Volunteers
News
Support
Institutions and libraries
Publishers
Institutional and library supporters
Apply
Application form
Guide to applying
The DOAJ Seal
Transparency & best practice
Publisher information
Licensing & copyright
Login
Login
Quick search
Close
×
Journals
Articles
Search by keywords:
In the field:
In all fields
Title
ISSN
Subject
Publisher
Country of publisher
Search
Frontiers in Allergy
(Jan 2023)
Corrigendum: Uncontrolled severe T2 asthma: Which biological to choose? A biomarker-based approach
Antolín López-Viña,
Rocio M. Diaz Campos,
Andrea Trisan Alonso,
Carlos Melero Moreno
Affiliations
Antolín López-Viña
Hospital Universitario Puerta de Hierro Majadahonda, Madrid, Spain
Rocio M. Diaz Campos
Hospital Universitario 12 de Octubre, Madrid, Spain
Andrea Trisan Alonso
Hospital Universitario Puerta de Hierro Majadahonda, Madrid, Spain
Carlos Melero Moreno
Fundación Investigación Biomédica Hospital 12 de Octubre, Madrid, Spain
DOI
https://doi.org/10.3389/falgy.2022.1119941
Journal volume & issue
Vol. 3
Abstract
Read online
No abstracts available.
Keywords
T2 severe asthma
monoclonal antibodies
biomarkers
exacerbations
systemic corticosteroids
WeChat QR code
Close
